Case Study:
AI-Driven Procurement & Supply Chain Optimization
From Spreadsheets to Smart Supply Chains: How AI Transformed Global Pharmaceutical Procurement
For a global pharmaceutical manufacturer operating across 30 sites in 18 countries — producing 2.3 billion packs of medicine annually — the stakes of supply chain inefficiency couldn’t be higher. Manual procurement processes, built on spreadsheets and ad-hoc communications, were struggling to keep pace with the complexity of managing upwards of 10,000 batches per year across a vast international network. Inconsistent supplier management, slow contract negotiations, and reactive inventory practices created mounting operational risk. This case study explores how Eularis helped the client harness AI-driven procurement and supply chain optimization to transform these challenges into a streamlined, predictive, and resilient operation — delivering tens of millions of dollars in cost avoidance and setting a new standard for pharmaceutical supply chain performance.
The Client
- Client’s pharmaceutical supply chain handles multiple packaging lines with upwards of 10,000 batches per year annually, producing 2.3 billion packs of medicine across a network of 30 sites in 18 countries
- Manual procurement processes created inefficiencies in supplier selection, contract negotiations, and inventory management across this massive global operation
- Traditional methods relied on spreadsheets, phone calls, and in-person meetings, resulting in inconsistent service quality and slower response times
The Solution
- Client implemented AI for procurement and supply chain optimisation, automating supplier selection and contract negotiations through advanced data analysis and predictive modelling to ensure optimal deals and timely deliveries of critical materials
- Real-time inventory monitoring and demand forecasting enabled AI to place orders automatically, preventing costly shortages or overstock situations
- AI’s ability to analyse supplier performance and market trends allowed for continuous optimisation of procurement strategies
The Outcome
Cost avoidance: Tens of millions of USD in lost batches avoided
Operational efficiency: Significant cost savings and enhanced operational efficiency across the pharmaceutical supply chain
Supply continuity: Prevented costly production disruptions through predictive inventory management and automated ordering amounts of data
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
The Copilot Delusion: Why “We Only Use Copilot” Is Not an AI Governance Strategy
Choosing one tool and writing a policy around it feels like control. Under the regulations now shaping pharma AI, it answers the wrong question entirely.
From Use Case to Working AI Agent Inside Your Pharma Environment
There is a specific pattern emerging across the pharmaceutical industry. Functional leaders in regulatory affairs, medical affairs, commercial, and market access have now seen enough
The Role of AI in Solving Clinical Trial Enrollment Challenges
Enrolment isn’t a “soft” operational risk in drug development – it’s the hard constraint that quietly determines whether a promising asset reaches patients on time